Anish Thomas

Anish Thomas

National Cancer Institute - Bethesda / United States
Others
AD Scientific Index ID: 4391221
person_outline Anish Thomas's MOST POPULAR ARTICLES
1-) Antibody–drug conjugates for cancer therapyA Thomas, BA Teicher, R HassanThe Lancet Oncology 17 (6), e254-e262, 20164292016
2-) Treatment of malignant pleural mesothelioma: American Society of Clinical Oncology clinical practice guidelineHL Kindler, N Ismaila, SG Armato III, R Bueno, M Hesdorffer, T Jahan, ...Journal of clinical oncology: official journal of the American Society of …, 20183342018
3-) Refining the treatment of NSCLC according to histological and molecular subtypesA Thomas, SV Liu, DS Subramaniam, G GiacconeNature reviews Clinical oncology 12 (9), 511-526, 20152742015
4-) Mesothelin immunotherapy for cancer: ready for prime time?R Hassan, A Thomas, C Alewine, DT Le, EM Jaffee, I PastanJournal of Clinical Oncology 34 (34), 4171-4179, 20163192016
5-) Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trialA Thomas, A Rajan, A Berman, Y Tomita, C Brzezniak, MJ Lee, S Lee, ...The Lancet Oncology 16 (2), 177-186, 20153162015